These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36004011)

  • 1. Persistent Relapsing Immune Thrombocytopenia Following COVID-19 Infection.
    Boehm BA; Packer CD
    Cureus; 2022 Jul; 14(7):e27133. PubMed ID: 36004011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune thrombocytopenia and COVID-19: Case report and review of literature.
    Alonso-Beato R; Morales-Ortega A; Fernández FJH; Morón AIP; Ríos-Fernández R; Rubio JLC; Centeno NO
    Lupus; 2021 Aug; 30(9):1515-1521. PubMed ID: 34053365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination.
    King ER; Towner E
    Am J Case Rep; 2021 Jul; 22():e931478. PubMed ID: 34285180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of COVID-19-Induced Immune Thrombocytopenia (ITP) in an Adult Female: An Under-Recognized Emerging Phenomenon.
    Ghukasyan H; Petrechko O; Choi H
    Cureus; 2023 Apr; 15(4):e38173. PubMed ID: 37122979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe immune thrombocytopenia that developed immediately after COVID-19 in a school-aged patient: A case report.
    Shinno K; Banno Y; Kamimaki I
    Front Pediatr; 2023; 11():1120093. PubMed ID: 37033169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccination associated severe immune thrombocytopenia.
    Shah SRA; Dolkar S; Mathew J; Vishnu P
    Exp Hematol Oncol; 2021 Jul; 10(1):42. PubMed ID: 34266487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent, Poorly Responsive Immune Thrombocytopenia Secondary to Asymptomatic COVID-19 Infection in a Child.
    Mettananda C; Williams S
    Case Rep Infect Dis; 2023; 2023():3298520. PubMed ID: 38145004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccination in patients with immune thrombocytopenia.
    Visser C; Swinkels M; van Werkhoven ED; Croles FN; Noordzij-Nooteboom HS; Eefting M; Last-Koopmans SM; Idink C; Westerweel PE; Santbergen B; Jobse PA; Baboe F; ; Te Boekhorst PAW; Leebeek FWG; Levin MD; Kruip MJHA; Jansen AJG
    Blood Adv; 2022 Mar; 6(6):1637-1644. PubMed ID: 34941989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
    Gao Y; Gong M; Zhang C; Kong X; Ma Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review.
    Bhattacharjee S; Banerjee M
    SN Compr Clin Med; 2020; 2(11):2048-2058. PubMed ID: 32984764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Possible Case of Nitrofurantoin-Associated Immune Thrombocytopenia in a Healthy 45-Year-Old Caucasian Female.
    Ramey C; LePera A
    Cureus; 2023 Feb; 15(2):e34654. PubMed ID: 36895539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe immune thrombocytopenia following diphtheria, tetanus, pertussis and polio vaccination in a 36-year-old Caucasian woman: a case report.
    Küster O; Schmohl J; Greiner J; Storz MA
    Eur J Med Res; 2022 May; 27(1):63. PubMed ID: 35505368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet count recovery after intravenous immunoglobulin predicts a favorable outcome in children with immune thrombocytopenia.
    Choi HS; Ji MH; Kim SJ; Ahn HS
    Blood Res; 2016 Jun; 51(2):95-101. PubMed ID: 27382553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
    Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A
    Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Thrombocytopenia Purpura Secondary to COVID-19.
    Bennett J; Brown C; Rouse M; Hoffmann M; Ye Z
    Cureus; 2020 Jul; 12(7):e9083. PubMed ID: 32676257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infant case of severe immune thrombocytopenia caused by COVID-19 infection.
    Anzai T; Nakashima N; Betsui H; Kawahara Y; Hayashi Y; Kimura H; Shimada A
    EJHaem; 2023 Nov; 4(4):1148-1151. PubMed ID: 38024599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Reactivation of Immune Thrombocytopenic Purpura After SARS-CoV-2 Infection.
    Posa DK; Kamoga GR; Walton R
    Cureus; 2023 Sep; 15(9):e44873. PubMed ID: 37692177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.
    Shiuan E; Beckermann KE; Ozgun A; Kelly C; McKean M; McQuade J; Thompson MA; Puzanov I; Greer JP; Rapisuwon S; Postow M; Davies MA; Eroglu Z; Johnson D
    J Immunother Cancer; 2017; 5():8. PubMed ID: 28239462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood immune thrombocytopenia: Clinical presentation and management.
    Faki Osman ME
    Sudan J Paediatr; 2012; 12(1):27-39. PubMed ID: 27493327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.